Jump to Navigation
Trends and Sentiments
Comments and Analysis
Bank Of America: Stage Set For Substantial Upside
The Criminal Acts Of Large Banks: Are Substantial Fines/...
Reddit Now Has An Official App To Help You Keep Track Of...
Using An App To Outsource Your Laundry Saves Time, If Not...
New York: Bank didn't lend to blacks in Buffalo
Amgen’s Heart Drug Runs Into Safety Concerns
Amazon and Google Battle for Drone Supremacy
Hollande affair actress wins privacy suit against French...
U.S. factory activity expands in August at fastest pace...
Gilead Sciences Is Not Done Running
Technology Leads Week With 5 IPO filings; 5 More Added To Calendar
8 U.S. IPOs Planned For The Week
IPO Preview: Cempra Holdings
2 Life Sciences IPOs Debut Below Target
Caesars Stands Out In A Busy IPO Week With Strong Returns
Trius Therapeutics: The Calm Before The Storm
2012 Biotech IPOs: Age Of The Dreamers?
2 Promising Biopharma Companies To Examine
Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured
Companies That Can Mend The Biotech Market: Stephen Brozak
Cempra's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Cempra Management Discusses Toyama Exclusive Agreement Conference (Transcript)
Cempra's CEO Presents at BARDA Contract Award Conference (Transcript)
Can Cempra Beat The Superbugs?
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Cempra's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Cempra's CEO Discusses Q3 2013 Results - Earnings Call Transcript
This Antibiotic Play May Be The Trius Of 2014
Cempra Holdings Hosts Solithromycin and Taksta Clinical Update Conference Call (Transcript)
Do Away With The Pill-A-Day Biotech Model: Steve Brozak
Cempra: Safety Results Solidifying Market Position
Cempra's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Promising Biotechs Target New Ways To Kill Bad Bugs: Venture Capitalist Dennis Purcell
Cempra's CEO Discusses Q1 2014 Results - Earnings Call Transcript
CEO Resigns After Being Caught On Video Kicking A...
Cycle of brutal sexual abuse of 1,400 children by...
EUR/GBP: 1.2575 USD/EUR: 1.3124 JPY/USD: 105.075
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions